Negative Isotype Controls
- Herpes simplex Virus 1 preparation is a cell lysate that is useful for a range of techniques, but contains soluble cytoplasmic proteins from the production cells.
Herpes simplex virus 1 (HSV1) is a member of the Herpesviridae viral family. It is a neurotropic virus that causes watery blisters on the skin or mucous membranes of humans. It is contagious and can be spread by close contact with an infected person who is producing and shedding virus from the skin. The virus is mostly latent in nerve cells of the body, but can occasionally travel to the skin, start shedding and may or may not produce the characteristic blisters. HSV1 is normally associated with cold sores on the mouth or lips, but may also be found on the genitals. There is no known cure for HSV infection and an infected person remains a carrier for life, however treatment can reduce viral shedding.
Clarified crude lysate containing HSV1 particles and proteins - liquid.
HSV1 is propagated in mammalian cells using a protocol optimised for maximum particle yield. At the appropriate time, infected cells are washed in saline and disrupted to release virus particles by freeze thaw and sonication.
Virus particles released from cells are partially purified by low speed centrifugation to remove cell debris. The product is then inactivated by heating to 56oC for 2 hours and by the addition of 0.01% Triton X-100. Inactivity is confirmed by double blind passage.
This product has been rendered inactive by standard procedures. However this material should still be handled as infectious and should be disposed of appropriately.
Approx. Protein Concentrations
Total protein concentration 1.1 mg/ml as determined by BCA assay.
Reagents In The Kit
Preparing The Antibody
Phosphate buffered saline
0.1% Triton X-100
Store at -70oC.
Storage in frost-free freezers is not recommended.
This product should be stored undiluted. Avoid repeated freezing and thawing as this may denature the protein. Should this product contain a precipitate we recommend microcentrifugation before use.
18 months from date of despatch.
For research purposes only
Additional Herpes simplex Virus 1 Formats
Recommended Secondary Antibody
Recommended Negative Isotype Control
Recommended Positive Controls